Discovery of substituted (4-phenyl-1H-imidazol-2-yl)methanamine as potent somatostatin receptor 3 agonists

Add time:08/22/2019    Source:sciencedirect.com

We report SAR studies on a novel non-peptidic somatostatin receptor 3 (SSTR3) agonist lead series derived from (4-phenyl-1H-imidazol-2-yl)methanamine. This effort led to the discovery of a highly potent low molecular weight SSTR3 agonist 5c (EC50 = 5.2 nM, MW = 359). The results from molecular overlays of 5c onto the L-129 structure indicate good alignment, and two main differences of the proposed overlays of the antagonist MK-4256 onto the conformation of 5c lead to inversion of antagonism to agonism.

We also recommend Trading Suppliers and Manufacturers of 3-(1H-IMIDAZOL-4-YL)-PROPYLAMINE HCL (cas 111016-57-0). Pls Click Website Link as below: cas 111016-57-0 suppliers

Prev:Tautomerism in 4-chlorophenyl benzoylcarbamodithioate: Experimental and DFT study
Next:Discovery of 5-(2-chloro-4′-(1H-imidazol-1-yl)-[1,1′-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPD)